Vise Technologies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
25,844
+2,394
+10% +$193K 0.02% 510
2026
Q1
$1.85M Hold
23,450
– – 0.04% 394
2025
Q4
$1.85M Buy
23,450
+3,778
+19% +$299K 0.04% 395
2025
Q3
$1.62M Sell
19,672
-2,026
-9% -$159K 0.06% 303
2025
Q2
$1.74M Buy
+21,698
New +$1.67M 0.07% 296
2024
Q4
$1.13M Buy
13,772
+7,785
+130% +$648K 0.09% 221
2024
Q3
$494K Buy
5,987
+3,106
+108% +$232K 0.06% 304
2024
Q2
$202K Sell
2,881
-312
-10% -$22.3K 0.04% 404
2024
Q1
$237K Sell
3,193
-510
-14% -$35.5K 0.05% 331
2023
Q4
$245K Sell
3,703
-328
-8% -$20.5K 0.05% 310
2023
Q3
$254K Buy
+4,031
New +$251K 0.06% 280
2023
Q2
– Sell
-3,535
Closed -$205K – 360
2023
Q1
$205K Sell
3,535
-719
-17% -$48.5K 0.05% 319
2022
Q4
$308K Sell
4,254
-507
-11% -$36.3K 0.1% 231
2022
Q3
$289K Sell
4,761
-481
-9% -$30.7K 0.11% 213
2022
Q2
$329K Buy
+5,242
New +$347K 0.13% 186

Other funds holding MET

Vise Technologies's MET Position: Q2 2026 in Review

Vise Technologies increased its MetLife (MET) stake by 10% in Q2 2026, buying an estimated $193K and bringing the position to 25,844 shares worth $2.19M. The position accounts for 0.02% of the portfolio, ranked #510.

Vise Technologies first reported a position in MET in Q2 2022 and has held it in 15 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Vise Technologies held 25,844 shares of MetLife worth $2.19M as of Q2 2026.
  • Vise Technologies bought 2,394 MetLife shares in Q2 2026, an estimated $193K.
  • MetLife made up 0.02% of Vise Technologies's portfolio in Q2 2026, its #510 holding.
  • Vise Technologies first reported a position in MetLife in Q2 2022 and has held it in 15 quarters since.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.